Affiliation:
1. Marion Merrell Dow Inc., Kansas City, Missouri 64134-0627, USA.
Abstract
The in vitro activity of the semisynthetic glycopeptide amide MDL 63,246 against 293 U.S. clinical isolates of gram-positive cocci was determined by the broth microdilution method. When compared with teicoplanin, MDL 63,246 had improved activity against Staphylococcus epidermidis (MICs that inhibited 90% strains tested [MIC90s], 0.25 versus 8 micrograms/ml, respectively). Staphylococcus haemolyticus (MIC90s, 1 versus 32 micrograms/ml, respectively), and VanA Enterococcus faecium (MIC90s, 32 versus > or = 1,024 micrograms/ml, respectively).
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference12 articles.
1. Genetics and mechanisms of glycopeptide resistance in enterococci;Arthur M.;Antimicrob. Agents Chemother.,1993
2. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147;Arthur M.;J. Bacteriol.,1992
3. Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infections;Berti M.;Antimicrob. Agents Chemother.,1992
4. In vitro activities of three semisynthetic amide derivatives of teicoplanin;Biavasco F.;MDL 62208, MDL 62211, and MDL 62873. Antimicrob. Agents Chemother.,1992
5. Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic;Goldstein B. P.;Antimicrob. Agents Chemother.,1995
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献